Seed VC · Langenthal, Switzerland
Pureos Bioventures is a venture capital firm based in Switzerland, specializing in investments in early-stage biotechnology and life sciences companies. Established in 2017, the firm focuses on supporting innovative therapeutics and platform technologies with the potential to address significant unmet medical needs. Pureos Bioventures is known for its experienced team and strong network within the biotech industry, enabling it to provide both capital and strategic guidance to portfolio companies. The firm has gained recognition for backing promising startups in Europe and North America, contributing to advancements in areas such as oncology, immunology, and rare diseases.
Business models
biotech_therapeutics
Customer segments
Researchers, Enterprise
Geography
Europe, APAC, US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Pureos Bioventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Pureos Bioventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Advice Capital
biotech, global equities
Seed VC
AgFunder
agrifoodtech, AI, biotech
Seed VC
Aloe Private Equity
deeptech, biotech
Seed VC
AMR Action Fund
biotech, antimicrobial resistance, antibiotics
Angel
Angel Academe - increasing female investment
cleantech, healthtech, fintech
Seed VC
Auxxo Female Catalyst Fund
climate tech, construction tech, biotech
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Pureos Bioventures is one of them, and we'll tell you exactly where they sit in your top 100.